Quick Takeaways
- Roger Pomerantz has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $108,416.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Roger Pomerantz
- Location
- Chalfont, PA
- Summary
- The estimated net worth of Roger Pomerantz is at least $108,416 dollars as of 18 Mar 2026. Roger Pomerantz is the Director of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $105.8K. Roger Pomerantz is the Director of Enlivex Ltd. and owns shares of Enlivex Ltd. (ENLV) stock worth about $2.6K.
- Signature
- /s/ Shachar Shlosberger, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Roger Pomerantz and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Viracta Therapeutics, Inc. ($105,837).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Roger Pomerantz
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VIRX | Viracta Therapeutics, Inc. | Director | $105,837 | 25 Nov 2024 | ||
| ENLV | Enlivex Ltd. | Director | $2,579 | 18 Mar 2026 | ||
| INDP | Indaptus Therapeutics, Inc. | Director | $0 | 10 Jun 2025 | ||
| CFRX | CONTRAFECT Corp | Chief Executive Officer, Director | 15 Feb 2022 |
Insider Transactions Reported by Roger Pomerantz:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.